Nedaplatin
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
Diammine[(hydroxy-κO)acetato(2-)-κO]platinum
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Routes of administration |
IV |
| Identifiers | |
| CAS Number | 95734-82-0  |
| ATC code | none |
| PubChem | CID: 6917890 |
| UNII | 8UQ3W6JXAN |
| KEGG | D01416 |
| Chemical data | |
| Formula | C2H8N2O3Pt |
| Molecular mass | 303.17 g/mol |
|
|
| (verify) | |
Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum-based antineoplastic drug which is used for cancer chemotherapy.[1] It produces less nausea, vomiting and nephrotoxicity than other platinum-containing drugs.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />- (Japanese) Aqupla アクプラ (PDF) Shionogi & Co. March 2007.
External links
- (Japanese) Official Shionogi & Co. Website
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs not assigned an ATC code
- Articles with Japanese-language external links
- Platinum compounds
- Platinum-based antineoplastic agents
- Antineoplastic and immunomodulating drug stubs
